Change of Name

Recorded: 2025-10-13 Pages: 6

Assignor

AUSPEX PHARMACEUTICALS, INC.

Executed: 2024-12-27

Assignee

AUSPEX PHARMACEUTICALS LLC

400 INTERPACE PARKWAY, PARSIPPANY, NEW JERSEY, 07054

Covered Properties (3)

Osmotic Dosage Forms Comprising Deutetrabenazine and Methods of Use Thereof

Patent: 12,589,075 →

Application: 18/609,809 →

Publication: US 2024/0307313

Osmotic Dosage Forms Comprising Deutetrabenazine and Methods of Use Thereof

Patent: 11,311,488 →

Application: 17/344,271 →

Publication: US 2021/0386673

Osmotic Dosage Forms Comprising Deutetrabenazine and Methods of Use Thereof

Patent: 12,599,598 →

Application: 17/835,435 →

Publication: US 2022/0296585